A novel treatment for fibromyalgia improves clinical outcomes in a community-based study.
Objectives: Immunoreactant load was assessed by using lymphocyte response assay [LRA] with cell response/blastogenic mixed cell culture to determine if substitution of reactive items would be associated with remission of symptoms in subjects with fibromyalgia syndrome [FMS]. Methods: Fibromyalgia su...
| Published in: | Journal of Musculoskeletal Pain Vol. 6; no. 2; pp. 133 - 150 |
|---|---|
| Main Authors: | , |
| Format: | research tables/charts Journal Article |
| Published: |
Taylor & Francis Ltd
1998
|
| Online Access: | View this record in EBSCOhost |